Speech-Language Pathologists in Lonetree, CO Accepting Medicare

3 Speech-Language Pathologists found. Showing 1 - 3

Ms. Sarah Caitlin Treharne, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8600 Park Meadows Dr, Suite 800, Lonetree, CO 80124 Phone: 303-985-1133    Fax: 720-962-0678

Rachael Falkowitz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10181 Park Meadows Dr, Lonetree, CO 80124 Phone: 954-895-7224

Leslie Berryman, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8600 Park Meadows Dr Ste 800, Lonetree, CO 80124 Phone: 303-985-1133

News Archive

NeoStem signs Collaborative Research Agreement with ImmuneRegen BioSciences

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China and ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc., announced today that they have entered into a Collaborative Research Agreement, focused on the development of an advanced, adult human stem cell product.

Study: Traffic-related air pollutants appear to thwart benefits of walking among older adults

Even short-term (2 hour) exposure to tiny particles of soot or dust found in traffic fumes on busy roads appears to thwart the benefits of walking on the heart and lungs among older adults (aged 60 or over), according to a study comparing the health effects of walking along a traffic-polluted road versus walking through a park.

Common risk factors for hepatocellular cancer

Among known risk factors for hepatocellular cancer, smoking, obesity, and heavy alcohol consumption, along with chronic hepatitis B and C infection, contribute to a large share of the disease burden in Europe, according to a cohort study published online October 21 in the Journal of the National Cancer Institute.

Affymetrix to acquire eBioscience

Affymetrix, Inc., and eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics, today announced they have amended their existing definitive agreement dated November 29, 2011 under which Affymetrix will acquire eBioscience.

New partnership to develop test for predicting disease course in pediatric Crohn's patients

The Crohn's & Colitis Foundation, the leading non-profit organization focused on both research and patient support for inflammatory bowel disease (IBD), has entered into a partnership with LifeArc, an independent medical research charity that advances translation of early science into health care treatments or diagnostics, to potentially develop the first clinical lab test to predict disease course in pediatric patients with Crohn's disease and response to treatment.

Read more Medical News

› Verified 2 days ago